NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000042511

Registered date:30/06/2021

Usefulness of zinc preparation administration in zinc deficiency dialysis patients

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedZinc deficiency Latent zinc deficiency
Date of first enrollment2020/10/19
Target sample size100
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeSerum zinc concentration ESA dose Hb Albumin leakage
Secondary Outcomeage Dialysis history Dialysis conditions Dialysate TSAT Ferritin Fedin administration period Ferromia oral dose Riona oral dose Pettle dose Total zinc dose TP Correction Ca P PTH K Mg Kt/V Beta 2 microglobulin HS-CRP Cr index Serum Alb nPCR ERI Lipid

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients receiving zinc preparations before the start of evaluation Patients who discontinued administration after exceeding the doctor's judgment and serum zinc concentration standard value Patients receiving more than the package insert of Polarezinc Orally Disintegrating Tablets

Related Information

Contact

public contact
Name Ryosuke Hatonari
Address 1-39 Kitasako 1bancho, Tokushima City, Tokushima Prefecture Japan 770-0011
Telephone 088-631-0110
E-mail r.hatonari@khg.or.jp
Affiliation Kawashima Hospital Group Faculty of Clinical Engineering
scientific contact
Name Ryosuke Hatonari
Address 6-1 Kitasako 1bancho, Tokushima City, Tokushima Prefecture Japan
Telephone 088-634-0200
E-mail r.hatonari@khg.or.jp
Affiliation Kawashima Hospital Group Faculty of Clinical Engineering